Medprin Regenerative Medical Technologies Co. Ltd. (301033) — Capital Reinvestment Ratio
Medprin Regenerative Medical Technologies Co. Ltd. (301033) has a Capital Reinvestment Ratio of 0.28x as of December 2024, meaning it reinvests 0% of its operating cash flow (CN¥116.38 Million) in capital expenditures (CN¥33.16 Million). See Medprin Regenerative Medical Technologie balance sheet independence to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Medprin Regenerative Medical Technologies Co. Ltd. Capital Reinvestment Ratio (2019–2024)
This chart tracks Medprin Regenerative Medical Technologies Co. Ltd.'s Capital Reinvestment Ratio across 6 annual periods. Check how aggressively does Medprin Regenerative Medical Technologie reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Medprin Regenerative Medical Technologies Co. Ltd. (2019–2024)
Year-by-year Capital Reinvestment Ratio for Medprin Regenerative Medical Technologies Co. Ltd. from 2019 to 2024. For live market cap and broader valuation context, see market value of Medprin Regenerative Medical Technologie.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.28x | CN¥116.38 Million | CN¥33.16 Million | ▼ -23.5% |
| 2023 | 0.37x | CN¥107.69 Million | CN¥40.09 Million | ▼ -86.8% |
| 2022 | 2.81x | CN¥48.31 Million | CN¥135.96 Million | ▲ +22.6% |
| 2021 | 2.30x | CN¥66.51 Million | CN¥152.71 Million | ▲ +26.3% |
| 2020 | 1.82x | CN¥33.91 Million | CN¥61.65 Million | ▲ +54.9% |
| 2019 | 1.17x | CN¥31.27 Million | CN¥36.71 Million | — |